In a median 11.3-year prospective study involving 5 145 individuals with type 2 diabetes, Lewis et al
With medication, expert guidance, and a vibrant community, Healthi makes healthy living simpler, smarter, and more effective
Medications known as glucagon-like peptide-1 receptor (GLP-1) agonists continue to rise in popularity thanks to their ability to help manage blood sugar levels and reduce hunger and food intake, thus potentially supporting weight loss
(Gross spending does not account for rebates that result in lower net spending.) Ozempic (semaglutide injection) was approved in December 2017
Biostimulators like Sculptra work differently from traditional fillers
Liraglutide and semaglutide: pooled post-hoc analysis to evaluate risk of dementia in patients with type 2 diabetes